PHARMACEUTICAL COMPOSITIONS CONTAINING COMBINED PLATELET AGGREGATION INHIBITING SUBSTANCES FOR USE IN THE TREATMENT AND PREVENTION OF ISCHEMIC VASCULAR EVENTS

摘要

The invention relates to the pharmaceutical industry in general and in particular to the pharmaceutical industry involved in the production of medicaments for controlling and preventing ischemic vascular events. More specifically, the invention relates to a composition comprising a combination of platelet aggregation inhibiting substances. The composition is characterised in that the aforementioned combination or association consists of a selected platelet aggregation inhibiting substance known as Clopidogrel and a platelet aggregation inhibiting substance having hypolipidaemic activity, known as Policosanol, in order to produce a produce which has a synergistic effect for the prevention and treatment of ischemic vascular events.